TABLE 1

Characteristics of the study participants

Malmö Case-Control
MPPPPP-Botnia StudyBPS
Case subjectsControl subjects
n (men/women)2,830 (1,667/1,163)3,550 (1,340/2,210)16,061 (10,416/5,645)3,298 (1,538/1,760)2,328 (1,065/1,263)
Age (years)57.9 ± 11.557.5 ± 6.045.5 ± 6.948.5 ± 15.945.5 ± 13.6
BMI (kg/m2)29.6 ± 5.525.1 ± 3.624.3 ± 3.326.2 ± 4.225.6 ± 3.9
Pfasting glucose (mmol/l)11.89 ± 4.344.78 ± 0.365.45 ± 0.565.16 ± 0.555.52 ± 0.57
HOMA-IR3.08 (2.38)0.67 (0.46)0.95 (1.16)0.60 (0.50)0.58 (0.40)
CIR149 (127)157.7 (163.3)112.2 (124.6)
ISI165 (170)144.9 (111.9)147.6 (111.3)
DI23,393 (27,302)22,535 (25,855)15,717 (18,334)
Follow-up time (years)24.8 (4.7)7.6 (5.2)
KCNQ1 rs2237895 RAF0.440.400.410.490.47
  • Data are means ± SD or median (interquartile range) unless otherwise indicated. Baseline characteristics are shown for MPP and BPS. RAF, risk allele frequency.